L LUSIS Trademark

Trademark Overview


On Wednesday, March 20, 2024, a trademark application was filed for L LUSIS with the United States Patent and Trademark Office. The USPTO has given the L LUSIS trademark a serial number of 98458857. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, November 5, 2024. This trademark is owned by Sansureus, Inc.. The L LUSIS trademark is filed in the Pharmaceutical Products category with the following description:

Injectable pharmaceuticals for treatment of anaphylactic reactions; Chemical reagents for medical purposes; Antibiotic tablets; Allergy tablets; Medicated water for the treatment of illnesses attributed to insufficient cellular energy; Medicated water for the treatment of allergies, cough, cold, flu, headache, pain; Medicated water for the treatment of infectious diseases, skin diseases and conditions, and internal diseases and conditions; Medicated water for the treatment of pain, nausea and muscle spasms; Medicated water-based solutions for treating skin infections and skin conditions; Medicated water for the treatment of gastrointestinal disorders; Antibiotic ointments; Anti-inflammatory ointments; Medicated ointments for treating dermatological conditions; Purified biochemical medical diagnostic reagents, namely, protein arrays, enzymes, and fluorescent dyes; Biochemical drugs for the treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the m...
l lusis

General Information


Serial Number98458857
Word MarkL LUSIS
Filing DateWednesday, March 20, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, November 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 5, 2024

Trademark Statements


Description of MarkThe mark consists of three circles, each missing a quarter forming the letter L, to the left of the word LUSIS.
Goods and ServicesInjectable pharmaceuticals for treatment of anaphylactic reactions; Chemical reagents for medical purposes; Antibiotic tablets; Allergy tablets; Medicated water for the treatment of illnesses attributed to insufficient cellular energy; Medicated water for the treatment of allergies, cough, cold, flu, headache, pain; Medicated water for the treatment of infectious diseases, skin diseases and conditions, and internal diseases and conditions; Medicated water for the treatment of pain, nausea and muscle spasms; Medicated water-based solutions for treating skin infections and skin conditions; Medicated water for the treatment of gastrointestinal disorders; Antibiotic ointments; Anti-inflammatory ointments; Medicated ointments for treating dermatological conditions; Purified biochemical medical diagnostic reagents, namely, protein arrays, enzymes, and fluorescent dyes; Biochemical drugs for the treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, inflammatory disorders, dermatological conditions, oncological diseases, blood diseases, connective tissue disorders, ophthalmic diseases, and gastroenterological disorders; Diagnostic preparations for medical purposes; Chemico-pharmaceutical preparations in the nature of biological indicators, in-vivo diagnostic agents, in-vitro diagnostic reagents for the diagnosis, monitoring, treatment and prevention of cancer, inflammatory disorders, oncological disorders, infectious diseases, and diseases related to the immune system and respiratory system; Chemical preparations in the nature of biological indicators, in-vivo diagnostic agents, in-vitro diagnostic reagents for the diagnosis, monitoring, treatment and prevention of cancer, inflammatory disorders, oncological disorders, infectious diseases, and diseases related to the immune system and respiratory systems; Chemical preparations in the nature of biological indicators, in-vivo diagnostic agents, in-vitro diagnostic reagents for the diagnosis, monitoring, treatment and prevention of cancer, inflammatory disorders, oncological disorders, infectious diseases, and diseases related to the immune system and respiratory system; Chemical reagents for medical or veterinary purposes
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 20, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLUSIS BIOSCIENCES, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHAYWARD, CA 94545

Party NameLUSIS BIOSCIENCES, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressHAYWARD, CA 94545

Party NameSansureus, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOntario, CA 91761

Trademark Events


Event DateEvent Description
Wednesday, March 20, 2024NEW APPLICATION ENTERED
Wednesday, August 14, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 15, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, September 27, 2024ASSIGNED TO EXAMINER
Saturday, September 28, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 16, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 5, 2024PUBLISHED FOR OPPOSITION
Tuesday, November 5, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, September 11, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP